These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 8599393)

  • 1. Serotonin-dopamine interaction and its relevance to schizophrenia.
    Kapur S; Remington G
    Am J Psychiatry; 1996 Apr; 153(4):466-76. PubMed ID: 8599393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serotonin in the action of atypical antipsychotic drugs.
    Meltzer HY
    Clin Neurosci; 1995; 3(2):64-75. PubMed ID: 7583621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.
    Di Pietro NC; Seamans JK
    Pharmacopsychiatry; 2007 Dec; 40 Suppl 1():S27-33. PubMed ID: 18080940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of serotonin in the pathophysiology and treatment of schizophrenia.
    Abi-Dargham A; Laruelle M; Aghajanian GK; Charney D; Krystal J
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):1-17. PubMed ID: 9017523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?
    Green AI; Zimmet SV; Strous RD; Schildkraut JJ
    Harv Rev Psychiatry; 1999; 6(6):287-96. PubMed ID: 10370435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of clozapine and risperidone on spatial working memory in schizophrenia.
    McGurk SR; Carter C; Goldman R; Green MF; Marder SR; Xie H; Schooler NR; Kane JM
    Am J Psychiatry; 2005 May; 162(5):1013-6. PubMed ID: 15863811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic clozapine, but not haloperidol, alters the response of mesoprefrontal dopamine neurons to stress and clozapine challenges in rats.
    Morrow BA; Rosenberg SJ; Roth RH
    Synapse; 1999 Oct; 34(1):28-35. PubMed ID: 10459169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F; Hasnat A; Haleem MA; Haleem DJ
    Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the biology of schizophrenia through the mechanism of action of clozapine.
    Brunello N; Masotto C; Steardo L; Markstein R; Racagni G
    Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile.
    Meltzer HY; Gudelsky GA
    Arzneimittelforschung; 1992 Feb; 42(2A):268-72. PubMed ID: 1586397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.
    Meltzer HY
    Psychopharmacology (Berl); 2002 Aug; 163(1):1-3. PubMed ID: 12185394
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.
    Horacek J; Bubenikova-Valesova V; Kopecek M; Palenicek T; Dockery C; Mohr P; Höschl C
    CNS Drugs; 2006; 20(5):389-409. PubMed ID: 16696579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benzodiazepines and schizophrenia, a review of the literature].
    Gaillard R; Ouanas A; Spadone C; Llorca PM; Lôo H; Baylé FJ
    Encephale; 2006; 32(6 Pt 1):1003-10. PubMed ID: 17372546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can 5-HT3 antagonists contribute toward the treatment of schizophrenia?
    Ellenbroek BA; Prinssen EP
    Behav Pharmacol; 2015 Feb; 26(1-2):33-44. PubMed ID: 25356732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
    Marek GJ
    Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.
    Meltzer HY
    Psychopharmacology (Berl); 1989; 99 Suppl():S18-27. PubMed ID: 2682729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.